Methods and compositions for modulating immune tolerance

Details for Australian Patent Application No. 2006297126 (hide)

Owner Government of the United States of America, as represented by the Secretary

Inventors Matsushima, Kouji; Biragyn, Arya; Bataar, Dolgor

Agent Pizzeys

Pub. Number AU-A-2006297126

PCT Pub. Number WO2007/041364

Priority 60/722,675 30.09.05 US

Filing date 28 September 2006

Wipo publication date 12 April 2007

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

24 April 2008 PCT application entered the National Phase

  PCT publication WO2007/041364 Priority application(s): WO2007/041364

26 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006297127-3-cyclyl-2- (4-sulfamo yl-phenyl) - n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes

2006297124-2-amino-7,8-dihydro-6H-pyrido(4,3-d) pyrimidin-5-ones